SCHEMBL13654498

SCHEMBL13654498

Cc1cc2nc(NC(=O)c3ccc(C(C)(C)N)cc3)cc(-c3ccccc3)n2n1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAP3K5 Q99683 3/20 0.47
▸ GRM5 P41594 4/20 0.45
▸ ALDH1A1 P00352 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAPT P10636 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1523792 0.91 MAP3K5 (0.47) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL12719592 0.89 ADORA3 (0.51) GRM5ALDH1A1POLBPKMMEN1
SCHEMBL1523680 0.89 MAP3K5 (0.45) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL1524426 0.88 MAP3K5 (0.45) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL1577090 0.87 MAP3K5 (0.46) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL1576785 0.87 MAP3K5 (0.46) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL1524518 0.87 MAP3K5 (0.45) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL1576787 0.87 MAP3K5 (0.46) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL1021190 0.87 MAP3K5 (0.45) MAP3K5GRM5ALDH1A1POLBPKM
SCHEMBL1576843 0.86 MAP3K5 (0.44) MAP3K5GRM5ALDH1A1POLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009123986-A1 APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-10-08 — — WO disclosed
Send feedback